Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Adagio Medical Holdings (ADGM) Gross Profit (2023 - 2025)

Adagio Medical Holdings has reported Gross Profit over the past 3 years, most recently at -$58000.0 for Q4 2025.

  • Quarterly Gross Profit changed N/A to -$58000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$624000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$684000.0 for FY2025, 58.99% up from the prior year.
  • Gross Profit was -$58000.0 for Q4 2025 at Adagio Medical Holdings, down from -$31000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at -$31000.0 in Q3 2025 and troughed at -$516000.0 in Q1 2024.
  • The 3-year median for Gross Profit is -$254500.0 (2023), against an average of -$254500.0.
  • Year-over-year, Gross Profit plummeted 33.02% in 2024 and then surged 89.01% in 2025.
  • A 3-year view of Gross Profit shows it stood at -$256000.0 in 2023, then fell by 10.16% to -$282000.0 in 2024, then soared by 79.43% to -$58000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADGM's Gross Profit are -$58000.0 (Q4 2025), -$31000.0 (Q3 2025), and -$253000.0 (Q1 2025).